TR201205029T1 - Teobromin içeren yavaş salınımlı tablet. - Google Patents
Teobromin içeren yavaş salınımlı tablet.Info
- Publication number
- TR201205029T1 TR201205029T1 TR2012/05029T TR201205029T TR201205029T1 TR 201205029 T1 TR201205029 T1 TR 201205029T1 TR 2012/05029 T TR2012/05029 T TR 2012/05029T TR 201205029 T TR201205029 T TR 201205029T TR 201205029 T1 TR201205029 T1 TR 201205029T1
- Authority
- TR
- Turkey
- Prior art keywords
- slow release
- theobromine
- weight
- release tablet
- release layer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Mevcut buluş, teobromin içeren yavaş salınımlı bir tabletle ilgilidir Daha özel bir ifadeyle mevcut buluş, teobromin içeren ve bir yavaş salınım tabakası ile bir hızlı salınım tabakasından oluşan yavaş salınımlı bir tabletle ilgili olup burada, yavaş salınım tabakası etken içerik olarak teobromini ağırlıkça %40 ila 60 oranında ve polietilen oksit ile hidroksipropil metilselülozdan oluşan bir yavaş salınım bazını ağırlıkça %14 ila 19 oranında içermekte ve hızlı salınım tabakası etken içerik olarak teobromini ağırlıkça %10 ila 30 oranında ve kroskarmeloz sodyum, krospovidon ile sodyum nişasta glikolat arasından seçilen bir veya daha fazla elemandan oluşan bir parçalayıcıyı ağırlıkça %0 5 ila 2 oranında içermektedir Mevcut buluşa uygun yavaş salınımlı tablet günde sadece bir kez alınması durumunda çeşitli öksürük semptomu tiplerinin etkin biçimde iyileştirmektedir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090105137A KR101137467B1 (ko) | 2009-11-02 | 2009-11-02 | 테오브로민 함유 서방성 정제 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201205029T1 true TR201205029T1 (tr) | 2012-09-21 |
Family
ID=43922740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2012/05029T TR201205029T1 (tr) | 2009-11-02 | 2010-09-01 | Teobromin içeren yavaş salınımlı tablet. |
Country Status (7)
Country | Link |
---|---|
KR (1) | KR101137467B1 (tr) |
CN (1) | CN102711740B (tr) |
BR (1) | BR112012010325B8 (tr) |
RU (1) | RU2506947C2 (tr) |
TR (1) | TR201205029T1 (tr) |
UA (1) | UA103558C2 (tr) |
WO (1) | WO2011052884A2 (tr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101220830B1 (ko) * | 2010-08-18 | 2013-01-10 | 안국약품 주식회사 | 테오브로민의 서방성 과립제 및 그 제조방법 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070196481A1 (en) * | 2002-07-25 | 2007-08-23 | Amidon Gregory E | Sustained-release tablet composition |
DE10353196A1 (de) * | 2003-11-13 | 2005-06-16 | Röhm GmbH & Co. KG | Mehrschichtige Arzneiform mit einer die Abgabe einer modulatorischen Substanz beeinflussenden Matrix |
KR20070017335A (ko) * | 2004-03-22 | 2007-02-09 | 노파르티스 아게 | 리카르바제핀을 포함하는 경구투여용 매트릭스 제제 |
CA2601339A1 (en) * | 2005-03-29 | 2006-10-05 | Roehm Gmbh | Multiparticulate pharmaceutical form comprising pellets with a matrix which influences the delivery of a modulatory substance |
KR100762847B1 (ko) * | 2006-01-27 | 2007-10-04 | 씨제이 주식회사 | 멀티플 유닛 타입 서방성 경구 제제 및 그 제조방법 |
-
2009
- 2009-11-02 KR KR1020090105137A patent/KR101137467B1/ko active IP Right Grant
-
2010
- 2010-09-01 TR TR2012/05029T patent/TR201205029T1/tr unknown
- 2010-09-01 UA UAA201206606A patent/UA103558C2/ru unknown
- 2010-09-01 WO PCT/KR2010/005911 patent/WO2011052884A2/ko active Application Filing
- 2010-09-01 RU RU2012119070/15A patent/RU2506947C2/ru active
- 2010-09-01 BR BR112012010325A patent/BR112012010325B8/pt not_active IP Right Cessation
- 2010-09-01 CN CN201080051266.9A patent/CN102711740B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN102711740A (zh) | 2012-10-03 |
BR112012010325A2 (pt) | 2016-03-29 |
RU2506947C2 (ru) | 2014-02-20 |
RU2012119070A (ru) | 2013-12-10 |
CN102711740B (zh) | 2014-02-12 |
BR112012010325B8 (pt) | 2021-05-25 |
WO2011052884A3 (ko) | 2011-07-14 |
WO2011052884A2 (ko) | 2011-05-05 |
UA103558C2 (ru) | 2013-10-25 |
KR101137467B1 (ko) | 2012-04-20 |
KR20110048367A (ko) | 2011-05-11 |
BR112012010325B1 (pt) | 2021-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1126116T1 (el) | Φαρμακευτικες συνθεσεις αποτελουμενες απο νιλοτινιμπη | |
FR2883179B1 (fr) | Comprime enrobe | |
NO20083630L (no) | Nye pyridinderivater | |
EA201400173A1 (ru) | Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства | |
MX342440B (es) | Derivados fluorados de aminotriazol. | |
CY1110097T1 (el) | Διπλοστοιβαδικο δισκιο για προληψη καρδιαγγειακων συμβαντων | |
CL2011002115A1 (es) | Compuestos derivados de 5-fenil-1h-piridin-2-ona y 5-fenil-pirazin-2-ona, inhibidores de la tirosina-quinasa de bruton (btk); proceso de preparación de los compuestos, compuesto intermediario, composición farmacéutica y uso en el tratamiento de enfermedades inflamatorias y/o autoinmunes. | |
NO20091395L (no) | Nye tiofenderivater | |
PT2242743E (pt) | Derivados de aminopirazol | |
ATE483707T1 (de) | 2-cyclopropylthiazolderivate | |
TN2012000371A1 (en) | Pyrazole compounds as crth2 antagonists | |
EA201190320A1 (ru) | Гетероциклические сульфонамиды, их применения и фармацевтические композиции | |
GEP20135859B (en) | Stable combined pharmaceutical composition | |
TR201010683A1 (tr) | Vildagliptin formülasyonları. | |
NO20084543L (no) | Benzimidazolderivater | |
CY1108231T1 (el) | Σταθερη στερεα δοσολογικη μορφη περιλαμβανουσα δεσμοπρεσσινη | |
TN2012000105A1 (en) | Spirolactam derivatives and uses of same | |
CY1109865T1 (el) | Συνθεσεις βαλσαρτανης | |
UY33305A (es) | Compuestos heterocíclicos inhibidores de DGAT1 | |
ATE533477T1 (de) | Pharmazeutische zusammensetzungen enthaltend irbesartan | |
TR201205029T1 (tr) | Teobromin içeren yavaş salınımlı tablet. | |
TR201803451T4 (tr) | Olmesartan formülasyonlari. | |
ATE438381T1 (de) | Zolpidemtabletten | |
TR201007926A1 (tr) | Prasugrel tablet formülasyonları. | |
MX2012007393A (es) | Composicion farmaceutica de disolucion rapida comprendiendo lornoxicam. |